Bruker Corporation
BRKR
$44.92
-$0.64-1.41%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 979.60M | 864.40M | 800.70M | 721.70M | 854.50M |
| Total Other Revenue | -- | -- | -- | -- | 13.10M |
| Total Revenue | 979.60M | 864.40M | 800.70M | 721.70M | 854.50M |
| Cost of Revenue | 481.00M | 437.60M | 402.50M | 362.20M | 420.10M |
| Gross Profit | 498.60M | 426.80M | 398.20M | 359.50M | 434.40M |
| SG&A Expenses | 244.10M | 230.20M | 222.70M | 195.00M | 206.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -13.70M | 12.10M | 2.60M | 3.30M | 1.80M |
| Total Operating Expenses | 815.80M | 778.00M | 720.00M | 642.30M | 712.30M |
| Operating Income | 163.80M | 86.40M | 80.70M | 79.40M | 142.20M |
| Income Before Tax | 54.60M | 55.10M | 23.70M | 71.80M | 241.70M |
| Income Tax Expenses | 40.70M | 14.80M | 16.10M | 19.80M | 37.10M |
| Earnings from Continuing Operations | 13.90M | 40.30M | 7.60M | 52.00M | 204.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -200.00K | 600.00K | -- | -1.10M | 900.00K |
| Net Income | 13.70M | 40.90M | 7.60M | 50.90M | 205.50M |
| EBIT | 163.80M | 86.40M | 80.70M | 79.40M | 142.20M |
| EBITDA | 216.70M | 137.40M | 125.90M | 114.10M | 179.50M |
| EPS Basic | 0.09 | 0.27 | 0.05 | 0.35 | 1.41 |
| Normalized Basic EPS | 0.63 | 0.32 | 0.32 | 0.36 | 0.56 |
| EPS Diluted | 0.09 | 0.27 | 0.05 | 0.35 | 1.41 |
| Normalized Diluted EPS | 0.63 | 0.32 | 0.32 | 0.36 | 0.56 |
| Average Basic Shares Outstanding | 151.60M | 151.50M | 147.40M | 145.20M | 145.50M |
| Average Diluted Shares Outstanding | 152.00M | 152.00M | 148.00M | 145.90M | 146.00M |
| Dividend Per Share | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Payout Ratio | 55.47% | 18.58% | 101.32% | 14.34% | 3.55% |
